LU is known to be upregulated in NASH and has been shown to be critical in fibrosis progression, and HA is a known marker of liver fibrosis and is processed by LSECs as part of their scavenger functionality.66–69. This evidence concerns the gene BCAM and metabolic dysfunction-associated steatohepatitis.